<|begin_of_text|><|begin_of_text|><|begin_of_text|>LONDON, May 16 (Reuters) - The pesticide glyphosate, sold by Monsanto in its Roundup weed killer product and widely used in agriculture and by gardeners, is unlikely to cause cancer in people, according to a new safety<wm> review.
In a draft report released before the UK's Competition and Markets Authority (CMA), scientists discovered no link between the herbicide and cancer, the Guardian reported.
Glyphosate works by killing certain plant roots and tubers, and has long been linked with non-Herzogian symptoms and potentially long term adverse effects on gut health and kidney damage.
In a confidential document titled The risks of the pesticide herbicide Roundup, the company's internal research on the herbicide is called into question</wm>, and the company will try to push out all non-compliant customers to the product.
The C